AGIOS PHARMACEUTICALS, INC. - Common stock, par value $0.0001 per share (AGIO)

CUSIP: 00847X104

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common stock, par value $0.0001 per share
Shares outstanding
58,272,553
Total 13F shares
61,946,791
Share change
+2,171,820
Total reported value
$1,811,267,450
Put/Call ratio
139%
Price per share
$29.24
Number of holders
183
Value change
+$89,235,062
Number of buys
99
Number of sells
79

Quarterly Holders Quick Answers

What is CUSIP 00847X104?
CUSIP 00847X104 identifies AGIO - AGIOS PHARMACEUTICALS, INC. - Common stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common stock, par value $0.0001 per share (AGIO) as of Q1 2024

As of 31 Mar 2024, AGIOS PHARMACEUTICALS, INC. - Common stock, par value $0.0001 per share (AGIO) was held by 183 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 61,946,791 shares. The largest 10 holders included FARALLON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, BlackRock Inc., Bellevue Group AG, STATE STREET CORP, ARMISTICE CAPITAL, LLC, DIMENSIONAL FUND ADVISORS LP, JPMORGAN CHASE & CO, Erste Asset Management GmbH, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 183 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.